Prelude Therapeutics Incorporated (PRLD)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
4. 20
+0.02
+0.4785%
$
249.93M Market Cap
- P/E Ratio
- Div Yield
180,700 Volume
-2 Eps
$ 4.18
Previous Close Investors:
Want to track PRLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Prelude Therapeutics Incorporated Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 John H. Burbank III Passport Capital LLC | 10.12M | $305.1M | $44.24M | -$260.86M | -85.5% |
 Point72 Asset Management LP Point72 Asset Management LP | 16,329 | $47,354.04 | $71,398.55 | $24,044.51 | 50.78% |
| DP Drew Phillips Fortitude Family Office LLC | 230 | $787 | $986.58 | $199.58 | 25.36% |
